Kalobios Pharmaceuticals Inc (KBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | KBIO | SLGL | CPHI | ||
| Company | Kalobios Pharmaceuticals Inc | Sol-Gel Technologies Ltd | China Pharma Holdings | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NYSE Arca | ||
| Open | 1.6500 | 62.43 | 1.3293 | ||
| High | 2.2000 | 66.50 | 1.3500 | ||
| Low | 1.6200 | 61.45 | 1.3000 | ||
| Latest | 2.1900 | 65.51 | 1.3300 | ||
| Change | +0.4630 | +2.57 | -0.0100 | ||
| % Change | +26.81% | +4.08% | -0.75% | ||
| Volume | 29,900 | 10,157 | 6,762 | ||
| 20-Day Average Volume | 12,700 | 21,141 | 41,253 | ||
| Previous Close | 1.7270 | 62.94 | 1.3400 | ||
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 1.7043 | 47.96 | 1.3227 | ||
| 20-Day Raw Stochastic | 98.57% | 98.19% | 27.27% | ||
| 20-Day Relative Strength | 60.40 | 78.84 | 43.75 | ||
| Weighted Alpha | -53.96 | +327.58 | -22.68 | ||
| Today's Opinion | N/A | 100% Buy | 88% Sell | ||
| Previous Opinion | N/A | 100% Buy | 88% Sell | ||
| Last Month's Opinion | N/A | 88% Buy | 80% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +36.88% since 07/28/17 | +23.97% since 01/07/26 | -1.48% since 01/07/26 | ||
| Low | 1.5700 on 08/02/17 | 51.00 on 01/08/26 | 1.2500 on 01/09/26 | ||
| High | 2.2000 on 08/04/17 | 66.50 on 01/14/26 | 1.7300 on 01/08/26 | ||
| 1-Month | |||||
| %Chg | +12.31% since 07/03/17 | +69.19% since 12/12/25 | -14.41% since 12/12/25 | ||
| Low | 1.5000 on 07/11/17 | 38.91 on 12/19/25 | 1.1800 on 12/26/25 | ||
| High | 2.2000 on 08/04/17 | 66.50 on 01/14/26 | 1.7300 on 01/08/26 | ||
| 3-Month | |||||
| %Chg | -5.60% since 05/04/17 | +66.04% since 10/14/25 | -29.03% since 10/14/25 | ||
| Low | 1.5000 on 07/11/17 | 28.81 on 11/13/25 | 1.1800 on 12/26/25 | ||
| High | 2.9500 on 05/17/17 | 66.50 on 01/14/26 | 1.9300 on 10/16/25 | ||
| 6-Month | |||||
| %Chg | -28.20% since 02/03/17 | +706.85% since 07/14/25 | -29.63% since 07/14/25 | ||
| Low | 1.5000 on 07/11/17 | 7.62 on 07/15/25 | 1.1800 on 12/26/25 | ||
| High | 3.2500 on 02/17/17 | 66.50 on 01/14/26 | 2.0299 on 09/09/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 32,806 | 175,338 | 6,729 | ||
| Shares Outstanding, K | 14,980 | 2,786 | 5,022 | ||
| Annual Sales | 0 | 11,540,000 | 4,530,000 | ||
| Annual Net Income | -27,010,000 | -10,580,000 | -4,740,000 | ||
| Last Quarter Sales | N/A | 400,000 | 760,000 | ||
| Last Quarter Net Income | N/A | -5,940,000 | -650,000 | ||
| 60-Month Beta | 2.99 | 1.35 | 1.03 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -2.13 on 11/20/25 | -0.17 on 11/12/25 | ||
| Latest Earnings Date | 09/22/17 | 05/05/26 | 02/11/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||